These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 6463946)

  • 1. [Quinidine and enzyme induction. Erroneous interpretation of the plasma levels of 3-hydroxyquinidine and O-demethylquinidine].
    Leroyer R; Jarreau C; Pays M
    Therapie; 1984; 39(1):57-9. PubMed ID: 6463946
    [No Abstract]   [Full Text] [Related]  

  • 2. Total and unbound concentrations of quinidine and 3-hydroxyquinidine at steady state.
    Wooding-Scott RA; Visco J; Slaughter RL
    Am Heart J; 1987 Feb; 113(2 Pt 1):302-6. PubMed ID: 3812182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic renal insufficiency. Elevated levels of the active metabolite (3-hydroxyquinidine) of quinidine].
    Camsonne R; Moulin MA; Ryckelynck JP; Mignot P; Albessard F; Perault M; Bigot MC; Richard O
    Nouv Presse Med; 1982 Oct; 11(41):3062-3. PubMed ID: 7145692
    [No Abstract]   [Full Text] [Related]  

  • 4. Determination of quinidine, dihydroquinidine, (3S)-3-hydroxyquinidine and quinidine N-oxide in plasma and urine by high-performance liquid chromatography.
    Nielsen F; Nielsen KK; Brøsen K
    J Chromatogr B Biomed Appl; 1994 Oct; 660(1):103-10. PubMed ID: 7858702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination kinetic of high polar metabolites pool of quinidine from human serum.
    Camsonne R; Moulin MA; Charbonneau P; Bazin C
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):74-5. PubMed ID: 3988396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high-pressure liquid chromatography method for serum quinidine and (3S)-3-hydroxyquinidine.
    Weidner N; Ladenson JH; Larson L; Kessler G; McDonald JM
    Clin Chim Acta; 1979 Jan; 91(1):7-13. PubMed ID: 761394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence supporting 3(S)-3-hydroxyquinidine-associated cardiotoxicity.
    Bowers LD; Nelson KM; Connor R; Lais CJ; Krauss E
    Ther Drug Monit; 1985; 7(3):308-12. PubMed ID: 4049469
    [No Abstract]   [Full Text] [Related]  

  • 8. Greater quinidine-induced QTc interval prolongation in women.
    Benton RE; Sale M; Flockhart DA; Woosley RL
    Clin Pharmacol Ther; 2000 Apr; 67(4):413-8. PubMed ID: 10801251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of effect of smoking on the metabolism and pharmacokinetics of quinidine in patients.
    Edwards DJ; Axelson JE; Visco JP; vanEvery S; Slaughter RL; Lalka D
    Br J Clin Pharmacol; 1987 Mar; 23(3):351-4. PubMed ID: 3567051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of 3-hydroxyquinidine following chronic quinidine therapy.
    Ackerman BH; Olsen KM; Pappas AA
    DICP; 1991; 25(7-8):867-9. PubMed ID: 1949948
    [No Abstract]   [Full Text] [Related]  

  • 11. [Plasma protein binding of 3-(S) or 3-(R) hydroxylated derivatives of quinidine and dihydroquinidine].
    Leroyer R; Varoquaux O; Guillebastres R; Jarreau C; Normand JP; Jaillon P; Advenier C; Pays M
    Therapie; 1986; 41(3):159-62. PubMed ID: 3750253
    [No Abstract]   [Full Text] [Related]  

  • 12. [Elimination half-life of 3-hydroxyquinidine in man].
    Camsonne R; Moulin MA; Bazin C; Charbonneau P; Drieu L; Pedailles S; Briand A
    Therapie; 1983; 38(1):115-6. PubMed ID: 6867995
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioavailability of two manufacturers' sustained-release quinidine gluconate tablets at steady state.
    Zinny MA; Taggart WV
    Clin Ther; 1984; 7(1):22-7. PubMed ID: 6518461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Simultaneous determination of quinidine and hydroquinidine in in the presence of benzodiazepine in human plasma].
    Quaglio MP; Bellini AM
    Farmaco Prat; 1988 Feb; 43(2):47-55. PubMed ID: 3396688
    [No Abstract]   [Full Text] [Related]  

  • 15. Phenytoin-induced changes in quinidine and 3-hydroxyquinidine pharmacokinetics in conscious dogs.
    Jaillon P; Kates RE
    J Pharmacol Exp Ther; 1980 Apr; 213(1):33-7. PubMed ID: 7359368
    [No Abstract]   [Full Text] [Related]  

  • 16. [Induction of quinidine-3-hydroxylase by phenobarbital in man].
    Camsonne R; Moulin MA; Potier C; Bazin C; Grollier G; Charbonneau P; Lacotte J; Albessard F
    Therapie; 1982; 37(6):692-4. PubMed ID: 7167872
    [No Abstract]   [Full Text] [Related]  

  • 17. Specific determination of quinidine and metabolites in biological fluids by reversed-phase high-performance liquid chromatography.
    Leroyer R; Jarreau C; Pays M
    J Chromatogr; 1982 Mar; 228():366-71. PubMed ID: 7076763
    [No Abstract]   [Full Text] [Related]  

  • 18. Steady-state bioavailability of two sustained-release quinidine preparations: quinidine gluconate versus quinidine sulfate.
    Taggart WV; Holyoak W
    Clin Ther; 1983; 5(4):357-64. PubMed ID: 6871920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between quinidine plasma level and clinical effect for a new quinidine retard-formulation (author's transl)].
    Gaul G; Aldor E
    Arzneimittelforschung; 1981; 31(9):1486-8. PubMed ID: 7197961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic analysis of intravenously and orally administered quinidine in cows.
    McGuirk SM; Muir WW; Sams RA
    Am J Vet Res; 1981 Sep; 42(9):1482-7. PubMed ID: 7325456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.